Logo-bi
Bioimpacts. 2018;8(3): 177-183. doi: 10.15171/bi.2018.20
PMID: 30211077        PMCID: PMC6128973

Original Research

Altered levels of immune-regulatory microRNAs in plasma samples of patients with lupus nephritis

Sepideh Zununi Vahed 1, Mohammadreza Nakhjavani 2, Jalal Etemadi 1, Henghame Jamshidi 1, Nima Jadidian 1, Tala Pourlak 1, Sima Abediazar *

Cited by CrossRef: 21

1- Zheng X, Zhang Y, Yue P, Liu L, Wang C, Zhou K, Hua Y, Wu G, Li Y, Chokesuwattanaskul R. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus. PLoS ONE. 2019;14(6):e0217523 [Crossref]
2- Xu N, Liu J, Li X. Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs. Front Physiol. 2022;13 [Crossref]
3- El-Akhras B, Talaat R, El-Masry S, Bassyouni I, El-Sayed I, Ali Y. Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus. Int J Immunopathol Pharmacol. 2023;37 [Crossref]
4- Cai Z, Xiang W, Peng X, Ding Y, Liao W, He X. MicroRNA-145 Involves in the Pathogenesis of Renal Vascular Lesions and May Become a Potential Therapeutic Target in Patients with Juvenile Lupus Nephritis. Kidney Blood Press Res. 2019;44(4):643 [Crossref]
5- Tsai C, Hsieh S, Lu C, Wu T, Liao H, Wu C, Li K, Kuo Y, Lee H, Shen C, Yu C. Cross-Talk between Mitochondrial Dysfunction-Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE. IJMS. 2019;20(20):5183 [Crossref]
6- Gachpazan M, Akhlaghipour I, Rahimi H, Saburi E, Mojarrad M, Abbaszadegan M, Moghbeli M. Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview. Autoimmun Highlights. 2021;12(1) [Crossref]
7- Garmaa G, Nagy R, Kói T, To U, Gergő D, Kleiner D, Csupor D, Hegyi P, Kökény G. Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis. BMC Nephrol. 2024;25(1) [Crossref]
8- So B, Yap D, Chan T. MicroRNAs in Lupus Nephritis–Role in Disease Pathogenesis and Clinical Applications. IJMS. 2021;22(19):10737 [Crossref]
9- Xu W, Feng S, Huang A. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review. Inflamm Res. 2022;71(12):1501 [Crossref]
10- Li Z, Wang R, Wang D, Zhang S, Song H, Ding S, Zhu Y, Wen X, Li H, Chen H, Liu S, Sun L, Ciccacci C. Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1. Journal of Immunology Research. 2023;2023:1 [Crossref]
11- Li J, Ma L, Yu H, Yao Y, Xu Z, Lin W, Wang L, Wang X, Yang H. MicroRNAs as Potential Biomarkers for the Diagnosis of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Front Med. 2022;8 [Crossref]
12- Khudhair I, Mohsen R, Alalwani A. Association of microRNA-155 gene polymorphism and the incidence of systemic lupus erythematosus in Iraqi patients. APJMBB. 2023;:96 [Crossref]
13- ElFeky D, Omar N, Shaker O, Abdelrahman W, Gheita T, Nada M. Circulatory microRNAs and proinflammatory cytokines as predictors of lupus nephritis. Front Immunol. 2024;15 [Crossref]
14- Tsai C, Shen C, Liao H, Li K, Lee H, Lu C, Wu C, Kuo Y, Hsieh S, Yu C. Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus. IJMS. 2019;20(16):3878 [Crossref]
15- Labib D, Koptan D, Ghoniem S, Salah S, El Shazly R, El Refai R. Dysregulation of microRNA146a-5p expression in systemic lupus erythematosus females: Diagnostic potential and association with ocular manifestations. The Egyptian Rheumatologist. 2020;42(2):117 [Crossref]
16- Mortazavi-Jahromi S, Aslani M, Mirshafiey A. A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunology Letters. 2020;227:8 [Crossref]
17- Tan G, Baby B, Zhou Y, Wu T. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus. Front Immunol. 2022;12 [Crossref]
18- Chen J, Wang M, Zhang Y, Zhu F, Xu Y, Yi G, Zheng R, Wu B. Platelet extracellular vesicles: Darkness and light of autoimmune diseases. International Reviews of Immunology. 2024;43(2):63 [Crossref]
19- Ibrahim S, Afify A, Fawzy I, El-Ekiaby N, Abdelaziz A. The curious case of miR-155 in SLE. Expert Rev Mol Med. 2021;23 [Crossref]
20- Selvaskandan H, Pawluczyk I, Barratt J. Clinical application of microRNAs in glomerular diseases. 2023;38(6):1375 [Crossref]
21- Liang J, Xie F, Feng J, Huang C, Shen J, Han Z, Luo W, He J, Chen H. Progress in the application of body fluid and tissue level mRNAs-non-coding RNAs for the early diagnosis and prognostic evaluation of systemic lupus erythematosus. Front Immunol. 2022;13 [Crossref]
22- Huang H. Immunotherapeutic approaches for systemic lupus erythematosus: early overview and future potential. 2023;3(6):452 [Crossref]
23- Nalewajska M, Gurazda K, Styczyńska-Kowalska E, Marchelek-Myśliwiec M, Pawlik A, Dziedziejko V. The Role of MicroRNAs in Selected Forms of Glomerulonephritis. IJMS. 2019;20(20):5050 [Crossref]
24- Alduraibi F, Tsokos G. Lupus Nephritis Biomarkers: A Critical Review. IJMS. 2024;25(2):805 [Crossref]
25- Jadideslam G, Ansarin K, Sakhinia E, Babaloo Z, Abhari A, Ghahremanzadeh K, Khalili M, Radmehr R, Kabbazi A. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review. Journal Cellular Physiology. 2019;234(12):21560 [Crossref]
26- Roointan A, Gholaminejad A, Shojaie B, Hudkins K, Gheisari Y. Candidate MicroRNA Biomarkers in Lupus Nephritis: A Meta-analysis of Profiling Studies in Kidney, Blood and Urine Samples. Mol Diagn Ther. 2023;27(2):141 [Crossref]
27- Wardowska A, Komorniczak M, Bułło-Piontecka B, Dȩbska-Ślizień M, Pikuła M. Transcriptomic and Epigenetic Alterations in Dendritic Cells Correspond With Chronic Kidney Disease in Lupus Nephritis. Front Immunol. 2019;10 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge